Related references
Note: Only part of the references are listed.Burden of Anemia in Chronic Kidney Disease Patients in Japan: A Literature Review
Tadao Akizawa et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2018)
Changes in the worldwide epidemiology of peritoneal dialysis
Philip Kam-Tao Li et al.
NATURE REVIEWS NEPHROLOGY (2017)
Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China
Nan Chen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Francesco Locatelli et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients
Anatole Besarab et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6-to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
Robert Provenzano et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
Robert Provenzano et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
An overview on safety issues related to erythropoiesis-stimulating agents for the treatment of anaemia in patients with chronic kidney disease
Lucia Del Vecchio et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
Anatole Besarab et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Prevalence of Anemia in Chronic Kidney Disease in the United States
Melissa E. Stauffer et al.
PLOS ONE (2014)
Peritoneal Dialysis-First Policy Made Successful: Perspectives and Actions
Philip Kam-tao Li et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Mechanisms of Anemia in CKD
Jodie L. Babitt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease
Yoshiharu Tsubakihara et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2010)
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
T Ganz
BLOOD (2003)
Share Paper
